ImmunoGen (IMGN) Pops Higher Following Positive T-DM1 Phase III Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- S&P 500 flat as chipmakers fall and bank earnings roll in
- Oil prices mixed as US-Russia diesel deal hopes offset Saudi Yemen attacks
- JPMorgan shares edge lower after third-quarter FICC revenue miss
- Fed’s Waller says US bond yield rise driven by growth, not inflation
- Wells Fargo beats profit estimates despite revenue miss
| Immunogen, Inc. (NASDAQ: IMGN) | Delayed: 31.25 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $31.25 | 52 Week High | $14.22 | |||
| Open | $240.83 | 52 Week Low | $1.51 | |||
| Day High | $31.25 | P/E | N/A | |||
| Day Low | $31.25 | EPS | $-0.36 | |||
| Volume | 670,938 | |||||
| Roche Holding AG Basel American Depositary Shares (AMEX: RHHBY) | Delayed: 53.81 -0.29 (0.54%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $54.10 | 52 Week High | $35.13 | |||
| Open | $54.55 | 52 Week Low | $28.10 | |||
| Day High | $54.57 | P/E | N/A | |||
| Day Low | $53.71 | EPS | $0.00 | |||
| Volume | 738,548 | |||||
